|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0008838,
umls-concept:C0008976,
umls-concept:C0010651,
umls-concept:C0013089,
umls-concept:C0013216,
umls-concept:C0025677,
umls-concept:C0030705,
umls-concept:C0042670,
umls-concept:C0600558,
umls-concept:C0683525,
umls-concept:C0684224,
umls-concept:C1519429,
umls-concept:C1555471
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2008-5-5
|
|
pubmed:abstractText |
Many patients with invasive urothelial cell cancer are poor candidates for cisplatin-based chemotherapy, and many are high risk for cystectomy. Southwest Oncology Group Trial 8733 was designed to address treatment for such patients.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/CA04919,
http://linkedlifedata.com/resource/pubmed/grant/CA12644,
http://linkedlifedata.com/resource/pubmed/grant/CA14028,
http://linkedlifedata.com/resource/pubmed/grant/CA16385,
http://linkedlifedata.com/resource/pubmed/grant/CA20319,
http://linkedlifedata.com/resource/pubmed/grant/CA22433,
http://linkedlifedata.com/resource/pubmed/grant/CA27057,
http://linkedlifedata.com/resource/pubmed/grant/CA32102,
http://linkedlifedata.com/resource/pubmed/grant/CA35176,
http://linkedlifedata.com/resource/pubmed/grant/CA35192,
http://linkedlifedata.com/resource/pubmed/grant/CA38926,
http://linkedlifedata.com/resource/pubmed/grant/CA46282,
http://linkedlifedata.com/resource/pubmed/grant/CA46441,
http://linkedlifedata.com/resource/pubmed/grant/CA58686,
http://linkedlifedata.com/resource/pubmed/grant/CA58861,
http://linkedlifedata.com/resource/pubmed/grant/CA76447
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:BakerLaurence HLH,
pubmed-author:CrawfordE DavidED,
pubmed-author:FaulknerJamesJ,
pubmed-author:HiganoCelestia SCS,
pubmed-author:HussainMahaM,
pubmed-author:MeyersFrederick JFJ,
pubmed-author:RivkinSaul ESE,
pubmed-author:RussellKenneth JKJ,
pubmed-author:SakrWael AWA,
pubmed-author:Southwest Oncology Group Trial 8733,
pubmed-author:TangenCatherine MCM
|
|
pubmed:copyrightInfo |
(c) 2008 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
112
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2181-7
|
|
pubmed:meshHeading |
pubmed-meshheading:18404692-Aged,
pubmed-meshheading:18404692-Aged, 80 and over,
pubmed-meshheading:18404692-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18404692-Carcinoma, Squamous Cell,
pubmed-meshheading:18404692-Carcinoma, Transitional Cell,
pubmed-meshheading:18404692-Chemotherapy, Adjuvant,
pubmed-meshheading:18404692-Cisplatin,
pubmed-meshheading:18404692-Combined Modality Therapy,
pubmed-meshheading:18404692-Cystectomy,
pubmed-meshheading:18404692-Doxorubicin,
pubmed-meshheading:18404692-Female,
pubmed-meshheading:18404692-Fluorouracil,
pubmed-meshheading:18404692-Humans,
pubmed-meshheading:18404692-Male,
pubmed-meshheading:18404692-Methotrexate,
pubmed-meshheading:18404692-Middle Aged,
pubmed-meshheading:18404692-Muscle Neoplasms,
pubmed-meshheading:18404692-Neoadjuvant Therapy,
pubmed-meshheading:18404692-Prognosis,
pubmed-meshheading:18404692-Survival Rate,
pubmed-meshheading:18404692-Treatment Outcome,
pubmed-meshheading:18404692-Urinary Bladder Neoplasms,
pubmed-meshheading:18404692-Vinblastine
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.
|
|
pubmed:affiliation |
Department of Medicine, Division of Oncology, University of Washington, Seattle, Washington, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
